These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 4858949)

  • 1. [Effects of dilazep on cardiac function, coronary circulation and myocardial energy metabolism].
    Katano Y; Takeda K; Otorii T; Horii D; Imai S
    Nihon Yakurigaku Zasshi; 1974 Mar; 70(2):305-14. PubMed ID: 4858949
    [No Abstract]   [Full Text] [Related]  

  • 2. [Animal experiment study on the coronary and circulatory effect of dipyridamole, carbocromen, hexobendine, dilazep and glucagon].
    Reploh HD
    Arzneimittelforschung; 1973 May; 23(5):629-39. PubMed ID: 4740201
    [No Abstract]   [Full Text] [Related]  

  • 3. [The pharmacology of the combination drug dilazep/beta-acetyldigoxin].
    Zechel VH; Brock N
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1905-14. PubMed ID: 4480353
    [No Abstract]   [Full Text] [Related]  

  • 4. Systemic and coronary hemodynamic effects of hexobendine and its interaction with adenosine and aminophylline.
    Hansing CE; Folts JD; Afonso S; Rowe GG
    J Pharmacol Exp Ther; 1972 Jun; 181(3):498-511. PubMed ID: 5033015
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pharmacology of 1,4-bis(3-(3,4,5-trimethoxybenzoyloxy)-propyl)-perhydro-1,4-diazepine (dilazep I.N.N.), a new coronary active substance].
    Lenke D; Brock N; Zechel HJ
    Arzneimittelforschung; 1972 Apr; 22(4):639-51. PubMed ID: 5068242
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of 1,4-bis(3-(3,4,5-trimethoxybenzoyl-oxy)-propyl)-perhydro-1,4-diazepine dihydrochloride on cardiac metabolism, hemodynamics and coronary and renal blood flow].
    Hensel I; Bretschneider HJ; Kettler D; Knoll D; Kochsiek K; Reploh HD; Spieckermann PG; Tauchert M
    Arzneimittelforschung; 1972 Apr; 22(4):652-63. PubMed ID: 5068243
    [No Abstract]   [Full Text] [Related]  

  • 7. Cerebral and coronary vascular effects of a symmetrical N,N'-disubstituted hexahydrodiazepine.
    Buyniski JP; Losada M; Bierwagen ME; Gardier RW
    J Pharmacol Exp Ther; 1972 Jun; 181(3):522-8. PubMed ID: 5033017
    [No Abstract]   [Full Text] [Related]  

  • 8. Systemic and hemodynamic effects of oral hexobendine in dogs.
    Hansing CE; Folts JD; Afonso S; Rowe GG
    Arzneimittelforschung; 1972 Feb; 22(2):398-402. PubMed ID: 5067494
    [No Abstract]   [Full Text] [Related]  

  • 9. Enhancement of coronary vasodilating action of adenosine by dilazep and dipyridamole in the dog.
    Sano N
    Jpn J Pharmacol; 1974 Jun; 24(3):471-8. PubMed ID: 4449152
    [No Abstract]   [Full Text] [Related]  

  • 10. Mechanism of enchancement of adenosine action by dipyridamole and lidoflazine, in dogs.
    Afonso S; O'Brien GS
    Arch Int Pharmacodyn Ther; 1971 Nov; 194(1):181-96. PubMed ID: 5123865
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of dilazep on blood flow and oxygen handling in the early stages of canine myocardial infarction. Simultaneous comparison with changes in the normal myocardium.
    Marshall RJ; Parratt JR
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 281(4):427-36. PubMed ID: 4275262
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacological studies on a new l,5-benzothiazepine derivative (CRD-401).
    Sato M; Nagao T; Yamaguchi I; Nakajima H; Kiyomoto A
    Arzneimittelforschung; 1971 Sep; 21(9):1338-43. PubMed ID: 5171789
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of lidoflazine on coronary circulation and myocardial metabolism in anesthetized and unanesthetized dogs.
    Takenaka T; Tachikawa S
    Arzneimittelforschung; 1970 Mar; 20(3):351-4. PubMed ID: 5467508
    [No Abstract]   [Full Text] [Related]  

  • 14. [The influence of intravenous administration of dilazep, beta-acetyldigoxin and dilazep/beta-acetyldigoxin on myocardial contractility in dogs].
    Zechel VH; Brock N
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1920-6. PubMed ID: 4480355
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cormelian (Dilazep) a new coronary active substance].
    Reuter H
    Z Allgemeinmed; 1974 Oct; 50(28):1255-6. PubMed ID: 4614598
    [No Abstract]   [Full Text] [Related]  

  • 16. Functional and metabolic effects of bupivacaine and lidocaine in the perfused working rat heart.
    Cronau LH; Merin RG; Abouleish E; Steenberg M; Melgarejo AB
    Anesth Analg; 1988 Oct; 67(10):929-35. PubMed ID: 3421496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative investigation on the vitro inhibition of adenosine decomposition by dilazep].
    Pohl VP; Brock N
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1901-5. PubMed ID: 4480272
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of hexobendine on the coronary efficacy of generalized hypoxia as well as of i.cor. and i.v. single injections of adenosine in dogs].
    Raberger G; Weissel M; Kraupp O
    Arzneimittelforschung; 1973 Jun; 23(6):764-8. PubMed ID: 4740758
    [No Abstract]   [Full Text] [Related]  

  • 19. [Dose-dependent effect of amrinone on hemodynamics, myocardial circulation and myocardial energy requirement. An experimental study].
    Veit S; Brückner JB; Vogt K; Wagner R; Hess W
    Z Kardiol; 1985 Feb; 74(2):76-84. PubMed ID: 3993153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of various coronary vasodilators on myocardial oxygen consumption.
    Oguro K; Kubota K; Kimura T; Hashimoto K
    Jpn J Pharmacol; 1973 Aug; 23(4):459-66. PubMed ID: 4202125
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.